Potential application and prevalence of the CD30 (Ki-1) antigen among solid tumors: A focus review of the literature
Keywords: CD30; Solid tumor; Non-hematopoetic; Non-lymphomatous; Ki-1; Brentuximab vedotin; Antibody-drug-conjugate;